Oil prices rose for a second day as uncertainty surrounding U.S.-Iran conflict resolution kept global crude supply concerns high. President Trump indicated ceasefire talks are struggling, while the U.S. plans to release oil from its reserves. Market attention now shifts to Trump’s China visit, with hopes of leveraging influence for a resolution.
Dr Reddy’s Laboratories Q4 Results: Cons PAT falls 86% YoY to Rs 221 crore, revenue dips 12%; Rs 8 per share dividend announced
Dr Reddy’s Laboratories Q4 Results: Dr. Reddy’s Laboratories reported a consolidated net profit at Rs 221 crore in the March-ended quarter versus Rs 1,587 crore